We’re thrilled to share insights from our recent participation in the esteemed glaucoma congress, Glaucoma 360. This annual event brings together industry leaders, clinicians, and stakeholders dedicated to advancing the…

Tsontcho (Sean) Ianchulev, MD, MPH, and colleagues reported on a new micro-interventional technique to enhance suprachoroidal outflow in patients with glaucoma at the American Academy of Ophthalmology annual meeting in…

Iantrek is excited to announce our participation in the upcoming AAO event. We’re bringing you two captivating presentations. 

Congratulations to Dr. Carol Toris and her team at the University of Nebraska Medical Center on their groundbreaking study on the outflow facility of single vs dual wall canalotomy. Their…

We are thrilled to announce that five of our very own clinicians and innovators at Iantrek have made it on the highly acclaimed Ophthalmologist Power List for 2023. Dr. Ike…

At the annual 2023 Glaucoma Research Foundation meeting, Dr, Ianchulev, Iantrek’s founder and Professor of Ophthalmology at New York Eye and Ear of Mount Sinai, gave the New Horizons Innovation…

At this year’s Glaucoma360 conference in San Francisco, world-renowned glaucoma specialists, scientists and industry gathered to discuss the latest advances in the diagnosis and treatment of glaucoma.

Dr. Ike Ahmed at the Moran Eye Institute reviews latest MIGS innovations and discusses Iantrek’s next generation micro-interventional technology for supraciliary bio-stenting. Read about the latest clinical experience with this advanced,…

Iantrek announces publication in the prestigious peer-review journal British Journal of Ophthalmology the results of a first-of-a-kind clinical investigation of supraciliary stenting – a novel MIGS approach to the suprachoroidal…

Welcome to the inaugural issue of Iantrek Quarterly, where you can find out about the latest happenings at the forefront of micro-interventional glaucoma technology. https://iantrekmed.com/newsletter/